Berberine and S allyl cysteine mediated amelioration of DEN + CCl4 induced hepatocarcinoma

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 1, 2014, Pages 219-244

  Sengupta, Dipanwita ^a   Chowdhury, Kaustav Dutta ^a   Sarkar, Avik ^a   Paul, Soumosish ^a   Sadhukhan, Gobinda Chandra ^a  

^a VIDYASAGAR COLLEGE   (India)

Author keywords

Berberine; Carbon tetrachloride; Di ethyl nitrosamine; Oxidative stress; p53 acetylation; S allyl cysteine

Indexed keywords

2 METHOXYESTRADIOL; AMITROLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BERBERINE; BUTHIONINE SULFOXIMINE; CARBON TETRACHLORIDE; CASPASE 3; CYTOCHROME P450 2E1; DICHLORODIHYDROFLUORESCEIN DIACETATE; DIETHYLDITHIOCARBAMIC ACID; DIETHYLNITROSAMINE; FLUOROCHROME; HEME OXYGENASE 1; HISTONE DEACETYLASE 1; LIPOCORTIN 5; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; PROTOPORPHYRIN ZINC; REACTIVE OXYGEN METABOLITE; S ALLYLCYSTEINE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL LABELING; CELL PROLIFERATION; CONTROLLED STUDY; CYTOFLUOROMETRY; DEACETYLATION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANALYSIS; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TOXICITY TESTING; TREATMENT DURATION;

ANIMALIA;

2′,7′-DICHLOROFLUORESCEIN DIACETATE, TCA, TRI CHOLORO-ACETIC ACID; 5,5-DITHIOBIS (2 NITROBENZOIC ACID); B; BERBERINE; BERBERINE TREATED GROUP; BOVINE SERUM ALBUMIN; BSA; C-JUN N TERMINAL KINASE; CARBON TETRACHLORIDE; CO-TREATED GROUP; CYP2E1; CYTOCHROMEP4502E1; DCFDA; DI ETHYL NITROSAMINE; DTNB; FACS; FITC; FLUORESCENCE ACTIVATED CELL SORTER; FLUOROCHROME ISO-THIOCYANATE; GLUTATHIONE REDUCTASE; GR; HDAC1; HEMOXYGENASE1; HISTONE DEACETYLASE TYPE1; HO1; JNK; MITOCHONDRIAL MEMBRANE POTENTIAL; MMP; NACN; NADPH; NBT/BCIP; NICOTINAMIDE ADENINE DINUCLEOTIDE 2′-PHOSPHATE REDUCED; NITRO BLUE TETRAZOLIUM/5-BROMO-4-CHLORO-3-INDOLYL PHOSPHATE; NRF2; NUCLEAR FACTOR ERYTHROID 2 RELATED FACTOR 2; OXIDATIVE STRESS; P53 ACETYLATION; PCNA; PHOSPHORYLATED MDM2; PMDM2; POST TREATED GROUP; POT; PP2A; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN PHOSPHATEASE 2A; PT; REACTIVE OXYGEN SPECIES; ROS; S; S ALLYL CYSTEINE; S+B; SAC TREATED GROUP; SOD; SODIUM CYANIDE; SUPEROXIDE DISMUTASE; TREATMENT WITH COMBINATION OF SAC AND BERBERINE;NS, NON SIGNIFICANT;

ALKYLATING AGENTS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERINE; BLOTTING, WESTERN; CARBON TETRACHLORIDE; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELLS, CULTURED; CYSTEINE; CYTOCHROME P-450 CYP2E1; CYTOCHROMES C; DIETHYLNITROSAMINE; FLOW CYTOMETRY; HEPATOCYTES; HISTONE DEACETYLASE 1; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; LIVER NEOPLASMS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84885353227     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.08.020     Document Type: Article

References (104)

1. W.Y. Lau, and E.C.H. Lai Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat. Dis. Int. 7 2008 237 257 (Pubitemid 351895383)
2. S. Caldwell, and S.H. Park The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumour biology J. Gastroenterol. 44 2009 96 101
3. A.A. Oyagbemi, O.I. Azeez, and A.B. Saba Hepatocellular carcinoma and the underlying mechanisms Afr. Health Sci. 10 2010 93 98
4. H. Nakagawa, and S. Maeda Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK Pathol. Res. Int. 2012 2012 1 14
5. C.D. Mann, C.P. Neal, G. Garcea, M.M. Manson, A.R. Dennison, and D.P. Berry Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis Eur. J. Cancer Prev. 18 2009 13 25
6. S.S. Lo, L.A. Dawson, E.Y. Kim, N.M. Mayr, J.Z. Wang, Z. Huang, and H.R. Cardenes Stereotactic body radiation therapy for hepatocellular carcinoma Discov. Med. 9 2010 404 410
7. L.A. Dawson, and C. Guha Hepatocellular carcinoma: radiation therapy Cancer J. 14 2008 111 116
8. J.J.G. Marin, B. Castano, P. Martinez-Becerra, R. Rosales, and M.J. Monte Chemotherapy in the treatment of primary liver tumours Cancer Ther. 6 2008 711 728
9. S. Okada Cancer chemoprevention as adjuvant therapy for hepatocellular carcinoma Jpn. J. Clin. Oncol. 31 2001 357 358 (Pubitemid 32958586)
10. C.W.L. Chua, and S.P. Choo Targeted therapy in hepatocellular carcinoma Int. J. Hepatol. 2011 2011 1 11
11. H. Sun, H. Hou, P. Lu, L. Zhang, F. Zhao, C. Ge, T. Wang, M. Yao, and J. Li Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis PLoS One 7 2012 e36808 10.1371/journal.pone.0036808
12. X.L. Guo, D. Li, F. Hu, J.R. Song, S.S. Zhang, W.J. Deng, K. Sun, Q.D. Zhao, X.Q. Xie, Y.J. Song, M.C. Wu, and L.X. Wei Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells Cancer Lett. 320 2012 171 179
13. S.H. Park, Y. Lee, S.H. Han, S.Y. Kwon, O.S. Kwon, S.S. Kim, J.H. Kim, Y.H. Park, J.N. Lee, S.M. Bang, E.K. Cho, D.B. Shin, and J.H. Lee Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma BMC Cancer 6 2006 1471 1476
14. L. Rossi, F. Zoratto, A. Papa, F. Iodice, M. Minozzi, L. Frati, and S. Tomao Current approach in the treatment of hepatocellular carcinoma World J. Gastrointest. Oncol. 2 2010 348 359
15. H. Ueda, H. Fukuchi, and C. Tanaka Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma Oncol. Lett. 3 2012 259 263
16. F. Korangy, B. Höchst, M.P. Manns, and T.F. Greten Immunotherapy of hepatocellular carcinoma Expert Rev. Gastroenterol. Hepatol. 4 2010 345 353
17. S. Díez, G. Navarro, and C.T. de ILarduya In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma J. Gene Med. 11 2009 38 45
18. M.P. Radosavljevic Hepatocellular carcinoma: the place of new medical therapies Ther. Adv. Gastroenterol. 3 2010 259 267
19. J.M. Llovet, and J. Bruix Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 2008 1312 1327
20. Y.F. Liu, B.S. Zha, H.L. Zhang, X.J. Zhu, Y.H. Li, J. Zhu, X.H. Guan, Z.Q. Feng, and J.P. Zhang Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model J. Exp. Clin. Cancer Res. 28 2009 107 123
21. S. Sundaresan, and P. Subramanian S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis Pol. J. Pharmacol. 55 2003 37 42 (Pubitemid 36411116)
22. S. Sundaresan, and P. Subramanian Prevention of N-nitrosodiethylamine- induced hepatocarcinogenesis by S-allylcysteine Mol. Cell. Biochem. 310 2008 209 214
23. X. Zhao, J.J. Zhang, X. Wang, X.Y. Bu, Q. Lou, and G.L. Zhang Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats Biomed. Pharmacother. 62 2008 567 572
24. J. Wongbutdee Physiological effects of berberine Thai Pharm. Health Sci. J. 4 2008 78 83
25. P.O. Seglen Preparation of isolated rat liver cells Methods Cell Biol. 13 1976 29 83
26. P. Inarrea, H. Moini, D. Han, D. Rettori, I. Aguilo, M.A. Alava, M. Iturralde, and E. Cadenas Mitochondrial respiratory chain and thioredoxin reductase regulate intermembrane Cu, Zn-superoxide dismutase activity: implications for mitochondrial energy metabolism and apoptosis Biochem. J. 405 2007 173 179 (Pubitemid 46999938)
27. P.X. Petit, M. Goubern, P. Diolez, S.A. Susin, N. Zamzami, and G. Kroemer Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition FEBS Lett. 426 1998 111 116 (Pubitemid 28198166)
28. J.D. Dignam, R.M. Lebovitz, and R.G. Roeder Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei Nucleic Acids Res. 11 1983 1475 1489
29. C. Domenicotti, D. Paola, A. Vitali, M. Nitti, D. Cottalasso, E. Melloni, G. Poli, U.M. Marinari, and M.A. Pronzato Mechanisms of inactivation of hepatocyte protein kinase C isoforms following acute ethanol treatment Free Radic. Biol. Med. 25 1998 529 535 (Pubitemid 28390308)
30. T.K. Chang, C.L. Crespi, and D.J. Waxman Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation Methods Mol. Biol. 320 2006 127 131
31. J.D. Kim, R.J.M. McCarter, and B.P. Yu Influence of age, exercise, and dietary restriction on oxidative stress in rats Aging Clin. Exp. Res. 8 1996 123 129
32. W. Stratford May, P.G. Tyler, T. Ito, D.K. Armstrong, K.A. Qatsha, and N.E. Davidson Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2α in association with suppression of apoptosis J. Biol. Chem. 269 1994 26665 26870
33. M.R.M. Harrison, A.S. Georgiou, H.P. Spaink, and V.T. Cunliffe The epigenetic regulator histone deacetylase1 promotes transcription of a core neurogenic programme in zebrafish embryos BMC Genomics 12 2011 24 41
34. C. Caron, C.P. Pajot, L.A. van Grunsven, E. Col, C. Lestrat, S. Rousseaux, and S. Khochbin Cdyl: a new transcriptional co-repressor EMBO Rep. 4 2003 877 882 (Pubitemid 37304405)
35. M.J. Marinissen, T. Tanos, M. Bolo, M.R. de Sagarra, O.A. Coso, and A. Cuadrado Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpes virus encoded G protein-coupled receptor J. Biol. Chem. 281 2006 11332 11346 (Pubitemid 43855558)
36. K.F. Chen, P.Y. Yeh, C. Hsu, C.H. Hsu, Y.S. Lu, H.P. Hsieh, P.J. Chen, and A.L. Cheng Bortezomib overcomes tumour necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/akt pathway J. Biol. Chem. 284 2009 11121 11133
37. A.S. Burke, L.A. MacMillan-Crow, and J.A. Hinson Reactive nitrogen species in acetaminophen-induced mitochondrial damage and toxicity in mouse hepatocytes Chem. Res. Toxicol. 23 2010 1286 1292
38. A. Bernareggi Clinical pharmacokinetics of nimesulide Clin. Pharmacokinet. 35 1998 247 274 (Pubitemid 28491213)
39. R. Schlatter, K. Schmich, A. Lutz, J. Trefzger, O. Sawodny, M. Ederer, and I. Merfort Modeling the TNFα-induced apoptosis pathway in hepatocytes PLoS One 6 2011 e18646 e18661
40. L. Huerta, L. Rancan, C. Simón, J. Isea, E. Vidaurre, E. Vara, I. Garuttic, and F.G. Aragoneses Ischaemic preconditioning prevents the liver inflammatory response to lung ischaemia/reperfusion in a swine lung autotransplant model Eur. J. Cardiothorac. Surg. 2012 10.1093/ejcts/ezs599
41. M.R. Cheng, Q. Li, T. Wan, B. He, J. Han, H.X. Chen, F.X. Yang, W. Wang, H.Z. Xu, T. Ye, and B.B. Zha Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects World J. Gastroenterol. 18 2012 6076 6087
42. W.F. Khalaf, H. White, M.J. Wenning, A. Orazi, R. Kapur, and D.A. Ingram K-Ras is essential for normal fetal liver erythropoiesis Blood 105 2005 3538 3541 (Pubitemid 40628197)
43. D.N. Roy, S. Mandal, G. Sen, S. Mukhopadhyay, and T. Biswas 14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO/cGMP pathway Br. J. Pharmacol. 160 2010 1823 1843
44. H. Tateossian, R.E. Hardisty-Hughes, S. Morse, M.R. Romero, H. Hilton, C. Dean, and S.D. Brown Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant Pathogenetics 2 2009 5 19
45. 4-induced hepatocellular carcinoma in Wistar rats Asian Pac. J. Trop. Med. 5 2012 623 629
46. M. Joo, Y.K. Kang, M.R. Kim, H.K. Lee, and J.J. Jang Cyclin D1 overexpression in hepatocellular carcinoma Liver 21 2001 89 95 (Pubitemid 32409535)
47. P. Parekh, and K.V. Rao Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis Cell Biol. Int. 31 2007 35 43 (Pubitemid 46124028)
48. L.X. Qin, and Z.Y. Tang The prognostic molecular markers in hepatocellular carcinoma World J. Gastroenterol. 8 2002 385 392
49. H. Yamazaki, Y. Oda, and Y. Funae Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain Carcinogenesis 13 1992 979 985
50. M. Kujawska, E. Ignatowicz, M. Murias, M. Ewertowska, K. Mikołajczyk, and J. Jodynis-liebert Protective effect of red beetroot against carbon tetrachloride- and N-Nitrosodiethylamine-induced oxidative stress in rats J. Agric. Food Chem. 57 2009 2570 2575
51. K.W. Kang, S.J. Lee, and S.G. Kim Molecular mechanism of Nrf2 activation by oxidative stress Antioxid. Redox Signal. 7 2005 1664 1673 (Pubitemid 41768000)
52. N. Weis, A. Weigert, A. von Knethen, and B. Brune Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants Mol. Biol. Cell. 20 2009 1280 1288
53. X. Deng, P. Ruvolo, B. Carr, and W.S. May Jr. Survival function of ERK1y2 as IL-3-activated, staurosporine-resistant Bcl2 kinases Proc. Natl. Acad. Sci. U. S. A. 97 2000 1578 1583 (Pubitemid 30118484)
54. V. Graupner, E. Alexander, T. Overkamp, O. Rothfuss, V. De Laurenzi, B.F. Gillissen, P.T. Daniel, K. Schulze-Osthoff, and F. Essmann Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level Cell Death Differ. 18 2011 1130 1139
55. W. Qiu, X. Wang, B. Leibowitz, W. Yang, L. Zhang, and J. Yu PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice Hepatology 54 2011 1249 1258
56. A. Insinga, S. Monestiroli, S. Ronzoni, R. Carbone, M. Pearson, G. Pruneri, G. Viale, E. Appella, P.G. Pelicci, and S. Minucci Impairment of p53 acetylation, stability and function by an oncogenic transcription factor EMBO J. 23 2004 1144 1154 (Pubitemid 38436878)
57. A. Ito, Y. Kawaguchi, C.H. Lai, J.J. Kovacs, Y. Higashimoto, E. Appella, and T. Yao MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation EMBO J. 21 2002 6236 6245 (Pubitemid 35415340)
58. Y. Ogawara, S. Kishishita, T. Obata, Y. Isazawa, T. Suzuki, K. Tanaka, N. Masuyama, and Y. Gotoh Akt enhances Mdm2-mediated ubiquitination and degradation of p53 J. Biol. Chem. 277 2002 21843 21850 (Pubitemid 34952337)
59. Y. Wang, Y.A. Suh, M.Y. Fuller, J.G. Jackson, S. Xiong, T. Terzian, A.Q. Cardama, J.A. Bankson, A.K. El-Naggar, and G. Lozano Restoring expression of wild-type p53 suppresses tumour growth but does not cause tumour regression in mice with a p53 missense mutation J. Clin. Invest. 121 2011 893 904
60. J.H. Mowatt, C. Dive, J.C. Martinou, and D. James Role of mitochondrial membrane permeabilization in apoptosis and cancer Oncogene 23 2004 2850 2860 (Pubitemid 38638847)
61. H. Higuchi, M. Adachi, S. Miura, G.J. Gores, and H. Ishii The mitochondrial permeability transition contributes to acute ethanol-induced apoptosis in rat hepatocytes Hepatology 34 2001 320 328 (Pubitemid 32702345)
62. D.E. Pritchard, J. Singh, D.L. Carlisle, and S.R. Patierno Cyclosporin A inhibits chromium (VI) induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells Carcinogenesis 21 2000 2027 2033
63. A.I. Vogel Practical Organic Chemistry 3rd ed. 1962 Pearson Education India
64. J.K. Lin Nitrosamines as potential environmental carcinogens in man Clin. Biochem. 23 1990 67 71 (Pubitemid 20134416)
65. P. Jakszyn, A. Agudo, R. Ibáñez, R.G. Closas, G. Pera, P. Amiano, and C.A. González Development of a food database of nitrosamines, heterocyclic amines, and polycyclic aromatic hydrocarbons J. Nutr. 134 2004 2011 2014 (Pubitemid 39036180)
66. V. Sharma, and M. Singh N-Nitrosodimethyl amine as a hazardous chemical toxicant in drinking water Int. Res. J. Pharm. 3 2012 60 65
67. S.E. Chuang, M.L. Kuo, C.H. Hsu, C.R. Chen, J.K. Lin, G.M. Lai, C.Y. Hsieh, and A.L. Cheng Curcumin-containing diet inhibits diethylnitrosamine- induced murine hepatocarcinogenesis Carcinogenesis 21 2000 331 335 (Pubitemid 30098723)
68. R. Peto, R. Gray, P. Brantom, and P. Grasso Dose and time relationships for tumour induction in the liver and oesophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine Cancer Res. 51 1991 6452 6469
69. W. Qiu, X. Wang, B. Leibowitz, W. Yang, L. Zhang, and J. Yu PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice Hepatology 54 2011 1249 1258
70. T. Sakurai, S. Maeda, L. Chang, and M. Karin Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation Proc. Natl. Acad. Sci. U. S. A. 103 2006 10544 10551 (Pubitemid 44078014)
71. 4-induced hepatocellular carcinoma in Wistar rats Asian Pac. J. Trop. Med. 5 2012 623 629
72. E. Pikarsky, R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah NF-kappaB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466 (Pubitemid 39329586)
73. N.M. Abdel-Hamid, M.A. Fawzy, and M.A. El-Moselhy Evaluation of hepatoprotective and anticancer properties of aqueous olive leaf extract in chemically induced hepatocellular carcinoma in rats Am. J. Med. Med. Sci. 1 2011 15 22
74. N. Sokkar, O. El-Gindi, S. Sayed, S. Mohamed, Z. Ali, I. Alfishawy, Antioxidant, anticancer and hepatoprotective activities of Cotoneaster horizontalis Decne extract as well as α-tocopherol and amygdalin production from in vitro culture, Acta Physiol. Plant, http://dx.doi.org/10. 1007/s11738-013-1276-z.
75. S. De, and S. De Gymnosporia montana, a potential hepatoprotective and anticancer druga - An overview Asian J. Pharm. Clin. Res. 5 2012 20 24
76. M.J. Wu, C.Y. Weng, H.Y. Ding, and P.J. Wu Anti-inflammatory and antiviral effects of Glossogyne tenuifolia Life Sci. 76 2005 1135 1146
77. X.H. Tang, J. Gao, Y.P. Wang, L.Z. Xu, X.N. Zhao, and Q. Xu Hepatoprotective effects of chloroform extract from leaf of Terminalia catappa in relation to the inhibition of liver IL-6 expression Zhongguo Zhong Yao Za Zhi 28 2003 1170 1174
78. B. Sun, and M. Karin NF-kappaB signaling, liver disease and hepatoprotective agents Oncogene 27 2008 6228 6244
79. S.E. Chuang, M.L. Kuo, C.H. Hsu, C.R. Chen, J.K. Lin, G.M. Lai, C.Y. Hsieh, and A.L. Cheng Curcumin-containing diet inhibits diethylnitrosamine- induced murine hepatocarcinogenesis Carcinogenesis 21 2000 331 335 (Pubitemid 30098723)
80. M.N.T. Attia, and M.A. Ali Hepatoprotective activity of allicin against carbon tetrachloride induced hepatic injury in rats J. Biol. Sci. 6 2006 457 468
81. H. Amagase Clarifying the real bioactive constituents of garlic J. Nutr. 136 2006 716 725
82. Y. Sun, K. Xun, Y. Wang, and X. Chen A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs Anticancer Drugs 20 2009 757 769
83. N. Tong, J. Zhang, Y. Chen, Z. Li, Y. Luo, H. Zuo, and X. Zhao Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro Oncol. Lett. 3 2012 1263 1267
84. A. Ravid, and R. Korean The role of reactive oxygen species in the anticancer activity of vitamin D Anticancer. Res. 164 2003 357 367
85. R.O. Recknagel, and E.A. Glende Jr. Carbon tetrachloride hepatotoxicitya - an example of lethal cleavage CRC Crit. Rev. Toxicol. 2 1973 263 297
86. S.S. Al-Rejaie, A.M. Aleisa, A.A. Al-Yahya, S.A. Bakheet, A. Alsheikh, A.G. Fatani, O.A. Al-Shabanah, and M.M. Sayed-Ahmed Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats World J. Gastroenterol. 15 2009 1373 1380
87. K.L. Cheung, S. Yu, Z. Pan, J. Ma, T.Y. Wu, and A.N.T. Kong tBHQ-Induced HO-1 expression is mediated by calcium through regulation of Nrf2 binding to enhancer and polymerase II to promoter region of HO-1 Chem. Res. Toxicol. 24 2011 670 676
88. S. Kongpetch, V. Kukongviriyapan, A. Prawan, L. Senggunprai, U. Kukongviriyapan, and B. Buranrat Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents PLoS One 7 2012 e34994 10.1371/journal.pone.0034994
89. C.R.P. Kruel, L.F.R. Pinto, T.C.M. Blanco, T.C. Barja-Fidalgo, L.L. Melo, and C.D.P. Kruel Evaluation of the heme oxygenase-1 expression in esophagitis and esophageal cancer induced by different reflux experimental models and diethylnitrosamine Acta Cir. Bras. 25 2010 304 310
90. J. Dulak, and A. Józkowicz Carbon monoxide - a "new" gaseous modulator of gene expression Acta. Biochim. Pol. 50 2003 31 47 (Pubitemid 37034226)
91. J. Cao, G. Drummond, K. Inoue, K. Sodhi, X.Y. Li, and S. Omura Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress Int. J. Mol. Sci. 9 2008 2388 2406
92. Z.N. Oltvai, C.L. Milliman, and S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax that accelerates programmed cell death Cell 74 1993 609 619 (Pubitemid 23259742)
93. L. Hui, K. Zatloukal, H. Scheuch, E. Stepniak, and E.F. Wagner Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation J. Clin. Invest. 118 2008 3943 3953
94. H. Nagata, E. Hatano, M. Tada, M. Murata, K. Kitamura, H. Asechi, M. Narita, A. Yanagida, N. Tamaki, S. Yagi, I. Ikai, K. Matsuzaki, and S. Uemoto Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumour-suppression in rat hepatocellular carcinoma Hepatology 49 2009 1944 1953
95. E.H. Xiao, J.Q. Li, and J.F. Huang Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization World J. Gastroenterol. 10 2004 190 194
96. V. Solozobova, A. Rolletschek, and C. Blattner Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage BMC Cell Biol. 10 2009 46 56
97. L. Chen, C. Shao, E. Cobos, J.S. Wang, and W. Gao 1,4-(Methylnitro- Samino)-1-(3-Pyridyl)-1-Butanone induces CRM1-dependent p53 nuclear accumulation in human bronchial epithelial cells Toxicol. Sci. 116 2010 206 215
98. I. Silins, N. Finnberg, A. Stahl, J. Hogberg, and U. Stenius Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat Carcinogenesis 22 2001 2023 2031 (Pubitemid 34065399)
99. G. Kroemer, and J.C. Reed Mitochondrial control of cell death Nat. Med. 6 2000 513 519 (Pubitemid 30305900)
100. S. Kanzler, and P.R. Galle Apoptosis and the liver Semin. Cancer Biol. 10 2000 173 184 (Pubitemid 30611679)
101. Y.N. Park, K.J. Chae, Y.B. Kim, C. Park, and N. Theise Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis Cancer 92 2001 2733 2738 (Pubitemid 33091908)
102. W. Bursch, B. Grasl-Kraupp, U. Wastl, K. Hufnagl, M. Chabicovsky, H. Taper, and R. Schulte-Hermann Role of apoptosis for mouse liver growth regulation and tumour promotion: comparative analysis of mice with high (C3H/He) and low (C57Bl/6 J) cancer susceptibility Toxicol. Lett. 149 2004 25 35 (Pubitemid 38469817)
103. Y. Li, L. Chen, T.H. Chan, M. Liu, K.L. Kong, J.L. Qiu, Y. Li, Y.F. Yuan, and X.Y. Guan SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice Gastroenterology 144 2013 179 191
104. H. Nakagawa, Y. Hirata, K. Takeda, Y. Hayakawa, T. Sato, H. Kinoshita, K. Sakamoto, W. Nakata, Y. Hikiba, M. Omata, H. Yoshida, K. Koike, H. Ichijo, and S. Maeda Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumour-suppressing function of stress-activated mitogen-activated protein kinase Hepatology 54 2011 185 195